Biogen Revenue Down as Multiple Sclerosis Sales Slide

Date:




Biogen swung to a loss as results were hurt by a double-digit decline in revenue from its core multiple sclerosis treatments.



Source link

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Here’s Why Dolly Parton Turned Down Elvis Presley

Dolly Parton's signature song, "I Will Always Love You,"...

Chevron, Other U.S. Firms Near Deal to Invest Billions in Venezuelan Oil Fields

The U.S. oil major is close to an agreement...

How every 2026 NFL draft pick has looked in the preseason

NFL NationAug 28, 2026, 06:20 AM ETCloseNFL Nation is...

Lindsay Clancy Trial: Verdict Watch Underway as Jurors Deliberate

IE 11 is not supported. For an optimal experience...